LD50=95 mg/kg (rat, IV); LD50=312 mg/kg (mouse, oral); LD50=103 mg/kg (mouse, IV); LD50=250 mg/kg (rabbit, IV)
A derivative of procaine with less CNS action.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Decamethonium | The therapeutic efficacy of Decamethonium can be increased when used in combination with Procainamide. |
| Neosaxitoxin | The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Procainamide. |
| Metocurine iodide | The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Procainamide. |
| Gallamine triethiodide | The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Procainamide. |
| Cisatracurium | Procainamide may increase the neuromuscular blocking activities of Cisatracurium. |
| Rocuronium | The therapeutic efficacy of Rocuronium can be increased when used in combination with Procainamide. |
| Atracurium besylate | The therapeutic efficacy of Atracurium besylate can be increased when used in combination with Procainamide. |
| Doxacurium | The therapeutic efficacy of Doxacurium can be increased when used in combination with Procainamide. |
| Mivacurium | The therapeutic efficacy of Mivacurium can be increased when used in combination with Procainamide. |
| Metocurine | The therapeutic efficacy of Metocurine can be increased when used in combination with Procainamide. |
| Pancuronium | The therapeutic efficacy of Pancuronium can be increased when used in combination with Procainamide. |
| Pipecuronium | The therapeutic efficacy of Pipecuronium can be increased when used in combination with Procainamide. |
| Vecuronium | The therapeutic efficacy of Vecuronium can be increased when used in combination with Procainamide. |
| Rapacuronium | The therapeutic efficacy of Rapacuronium can be increased when used in combination with Procainamide. |
| Atracurium | The therapeutic efficacy of Atracurium can be increased when used in combination with Procainamide. |
| Gallamine | The therapeutic efficacy of Gallamine can be increased when used in combination with Procainamide. |
| Alcuronium | The therapeutic efficacy of Alcuronium can be increased when used in combination with Procainamide. |
| Tubocurarine | The therapeutic efficacy of Tubocurarine can be increased when used in combination with Procainamide. |
| Pyrantel | The therapeutic efficacy of Pyrantel can be increased when used in combination with Procainamide. |
| Fingolimod | Fingolimod may increase the arrhythmogenic activities of Procainamide. |
| Propafenone | Propafenone may increase the arrhythmogenic activities of Procainamide. |
| Cimetidine | The serum concentration of Procainamide can be increased when it is combined with Cimetidine. |
| Dipyridamole | The therapeutic efficacy of Procainamide can be decreased when used in combination with Dipyridamole. |
| Ephedrine | Procainamide may increase the neuromuscular blocking activities of Ephedrine. |
| Bambuterol | Procainamide may increase the neuromuscular blocking activities of Bambuterol. |
| Sar9, Met (O2)11-Substance P | Procainamide may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Procaine | Procainamide may increase the neuromuscular blocking activities of Procaine. |
| Chloroprocaine | Procainamide may increase the neuromuscular blocking activities of Chloroprocaine. |
| Trimethaphan | Procainamide may increase the neuromuscular blocking activities of Trimethaphan. |
| Butyrylthiocholine | Procainamide may increase the neuromuscular blocking activities of Butyrylthiocholine. |
| Oxybuprocaine | Procainamide may increase the neuromuscular blocking activities of Oxybuprocaine. |
| Benzonatate | Procainamide may increase the neuromuscular blocking activities of Benzonatate. |
| Ranitidine | The serum concentration of Procainamide can be increased when it is combined with Ranitidine. |
| Succinylcholine | The metabolism of Succinylcholine can be decreased when combined with Procainamide. |
| Mirabegron | The serum concentration of Procainamide can be increased when it is combined with Mirabegron. |
| Sulpiride | The risk or severity of adverse effects can be increased when Procainamide is combined with Sulpiride. |
| Acetyldigitoxin | Acetyldigitoxin may increase the arrhythmogenic activities of Procainamide. |
| Carteolol | Procainamide may increase the arrhythmogenic activities of Carteolol. |
| Tocainide | Procainamide may increase the arrhythmogenic activities of Tocainide. |
| Deslanoside | Procainamide may increase the arrhythmogenic activities of Deslanoside. |
| Metipranolol | Procainamide may increase the arrhythmogenic activities of Metipranolol. |
| Cyclandelate | Procainamide may increase the arrhythmogenic activities of Cyclandelate. |
| Seletracetam | Procainamide may increase the arrhythmogenic activities of Seletracetam. |
| Nylidrin | Procainamide may increase the arrhythmogenic activities of Nylidrin. |
| Dotarizine | Procainamide may increase the arrhythmogenic activities of Dotarizine. |
| Xylometazoline | Procainamide may increase the arrhythmogenic activities of Xylometazoline. |
| Tranilast | Procainamide may increase the arrhythmogenic activities of Tranilast. |
| Fasudil | Procainamide may increase the arrhythmogenic activities of Fasudil. |
| Barnidipine | Procainamide may increase the arrhythmogenic activities of Barnidipine. |
| Azelnidipine | Procainamide may increase the arrhythmogenic activities of Azelnidipine. |
| Cilnidipine | Procainamide may increase the arrhythmogenic activities of Cilnidipine. |
| Darodipine | Procainamide may increase the arrhythmogenic activities of Darodipine. |
| Niludipine | Procainamide may increase the arrhythmogenic activities of Niludipine. |
| Carboxyamidotriazole | Procainamide may increase the arrhythmogenic activities of Carboxyamidotriazole. |
| Naftopidil | Procainamide may increase the arrhythmogenic activities of Naftopidil. |
| Vinpocetine | Procainamide may increase the arrhythmogenic activities of Vinpocetine. |
| Cymarin | Procainamide may increase the arrhythmogenic activities of Cymarin. |
| Metildigoxin | Procainamide may increase the arrhythmogenic activities of Metildigoxin. |
| Tiracizine | Procainamide may increase the arrhythmogenic activities of Tiracizine. |
| Ethacizine | Procainamide may increase the arrhythmogenic activities of Ethacizine. |
| Hydroquinine | Procainamide may increase the arrhythmogenic activities of Hydroquinine. |
| Bioallethrin | Procainamide may increase the arrhythmogenic activities of Bioallethrin. |
| Caroverine | Procainamide may increase the arrhythmogenic activities of Caroverine. |
| Fosfructose | Procainamide may increase the arrhythmogenic activities of Fosfructose. |
| WIN 55212-2 | Procainamide may increase the arrhythmogenic activities of WIN 55212-2. |
| Fish oil | Procainamide may increase the arrhythmogenic activities of Fish oil. |
| Emopamil | Procainamide may increase the arrhythmogenic activities of Emopamil. |
| Lomerizine | Procainamide may increase the arrhythmogenic activities of Lomerizine. |
| Tetrandrine | Procainamide may increase the arrhythmogenic activities of Tetrandrine. |
| Dexniguldipine | Procainamide may increase the arrhythmogenic activities of Dexniguldipine. |
| Fosinoprilat | Procainamide may increase the arrhythmogenic activities of Fosinoprilat. |
| Hydroquinidine | Procainamide may increase the arrhythmogenic activities of Hydroquinidine. |
| SOR-C13 | Procainamide may increase the arrhythmogenic activities of SOR-C13. |
| Dexpropranolol | Procainamide may increase the arrhythmogenic activities of Dexpropranolol. |
| Nimodipine | Nimodipine may increase the arrhythmogenic activities of Procainamide. |
| Atropine | Atropine may increase the arrhythmogenic activities of Procainamide. |
| Adenosine | Adenosine may increase the arrhythmogenic activities of Procainamide. |
| Levosimendan | Levosimendan may increase the arrhythmogenic activities of Procainamide. |
| Prenylamine | Procainamide may increase the arrhythmogenic activities of Prenylamine. |
| Fluspirilene | Procainamide may increase the arrhythmogenic activities of Fluspirilene. |
| Azimilide | Procainamide may increase the arrhythmogenic activities of Azimilide. |
| Tedisamil | Procainamide may increase the arrhythmogenic activities of Tedisamil. |
| Nilvadipine | Procainamide may increase the arrhythmogenic activities of Nilvadipine. |
| Fendiline | Procainamide may increase the arrhythmogenic activities of Fendiline. |
| Eperisone | Procainamide may increase the arrhythmogenic activities of Eperisone. |
| Benidipine | Procainamide may increase the arrhythmogenic activities of Benidipine. |
| Simendan | Procainamide may increase the arrhythmogenic activities of Simendan. |
| Otilonium | Procainamide may increase the arrhythmogenic activities of Otilonium. |
| Nizofenone | Procainamide may increase the arrhythmogenic activities of Nizofenone. |
| Bunaftine | Procainamide may increase the arrhythmogenic activities of Bunaftine. |
| Lorcainide | Procainamide may increase the arrhythmogenic activities of Lorcainide. |
| Penfluridol | Procainamide may increase the arrhythmogenic activities of Penfluridol. |
| Dexverapamil | Procainamide may increase the arrhythmogenic activities of Dexverapamil. |
| Isradipine | Isradipine may increase the arrhythmogenic activities of Procainamide. |
| Trimethadione | Trimethadione may increase the arrhythmogenic activities of Procainamide. |
| Digoxin | Digoxin may increase the arrhythmogenic activities of Procainamide. |
| Hyoscyamine | Hyoscyamine may increase the arrhythmogenic activities of Procainamide. |
| Ethosuximide | Ethosuximide may increase the arrhythmogenic activities of Procainamide. |
| Losartan | Losartan may increase the arrhythmogenic activities of Procainamide. |
| Moricizine | Moricizine may increase the arrhythmogenic activities of Procainamide. |